이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Strategies for Suspected Pulmonary Embolism in Emergency Departments

2009년 2월 4일 업데이트: University Hospital, Angers

Strategies for Suspected Pulmonary Embolism in Emergency Departments - SPEED Study

Aims: 1) To evaluate the effectiveness of two interventions aimed at improving the management of patients with suspected pulmonary embolism: Written guidelines and Computer-Assisted Decision Support (CADS). 2) To evaluate the impact of electronic reminders on the appropriateness of the treatment of patients with suspected PE

Design: Pragmatic, unblinded, cluster randomised controlled study.

Setting: 20 French Emergency Departments

Patients: Out patients suspected of having pulmonary embolism

Methods: Emergency physicians will prospectively complete a standardized electronic form on Personal Data Assistant (PDA), including patients' characteristics, the clinical probability if assessed, the diagnostic tests performed, the treatments initiated and the final diagnostic and therapeutic decisions. Patients will be interviewed at the end of a 3-month follow-up period using a standardized questionnaire.

The reference rate of appropriateness of the diagnostic management before intervention will be assessed in each centre. At the end of this preliminary period, the centres will be randomized in two fold two groups according to a factorial design with stratification on their reference level of appropriateness. Half of the centres will have written guidelines and half a Computer-Assisted Decision Support for the diagnosis of PE on the PDA. In each of these two main groups, half of the centres will have electronic reminders on their PDA concerning the treatment of PE.

Judgment criteria

Main : Rate of strategies considered as validated according to the results of the systematic review and meta-analysis.3

Secondary judgment criteria (diagnosis):

  • Rate of strategies considered as validated or acceptable according to the opinion of international advisors.
  • Rate of thromboembolic-events during a 3-month follow-up period in patients for whom pulmonary embolism will be ruled out
  • Costs of the diagnostic management

Secondary judgment criteria (treatment):

  • Delay between Emergency Department admission and the first dose of antithrombotic treatment in patients with high clinical probability of PE according to the Revised Geneva Score
  • Rate of inappropriate treatment according to international recommendations for patients with confirmed PE.

Number of patients: By estimating that the rate of appropriateness would be 55% in the "written guidelines" group, 1331 patients are necessary to highlight an absolute superiority of 15% in the "CADS" group (rate of conformity of 70%).

The number of patients will be adjusted at the end of the preliminary period according to the level of appropriateness before interventions considering that it will improve less than 5% in the "written guidelines" group.

연구 개요

상세 설명

Background: The management of patients with suspected pulmonary embolism (PE) represents an important medical and economic issue. In French Emergency Departments, more than 100 000 suspicions of PE are dealt with per year. In a previous work, we found that the routine diagnostic practice differs to a large extent from international guidelines and that excluding PE on the basis of inappropriate criteria exposes patients to a six-fold increased risk of venous thromboembolism during 3-months follow-up.1 Passive interventions to improve quality are generally ineffective but Computer-Assisted Decision Support and reminders appear as promising.2

Interventions:

At the end of the preliminary period, we will perform for all the investigators, an interactive oral presentation of the strategies considered as validated on the basis of a systematic review and meta-analysis.3 A strategy end up to exclude PE is considered as validated if the probability of PE is below 5% and a strategy end up to confirm PE is considered as validated if the probability of PE is upper than 85%. The strategies that do not achieve these criteria but considered as acceptable by international advisors will be presented too as well as the recommendations for the treatment of PE.4 In the group "written guidelines", emergency physicians will be provided with cards presenting the list of the validated and acceptable strategies as well as the Geneva diagnostic algorithm.5 The algorithm will be mention as a way to follow appropriate diagnostic criteria.

In the "CADS" group, the recommendations will be integrated into the electronic form allowing calculation of the pre-test probability according to revised Geneva Score 6, calculation of the post-test probabilities according to the likelihood ratios of the tests 3 and contextualized reminders as which test perform or when stop investigations.

In the groups "treatment help", reminders concerning the treatment (indications and contraindications, dosage) will be integrated into the electronic form on the PDA.

  1. Roy PM, Meyer G, Vielle B, Legall C, Verschuren F, Furber A. Inappropriateness of Diagnostic Management in Patients with Suspected Pulmonary Embolism: Frequency, Predictors and Association with Outcome. J Thromb Haemost 2005; 3:OR 304.
  2. Grimshaw JM, Shirran L, Thomas R, et al. Changing provider behavior: an overview of systematic reviews of interventions. Med Care 2001; 39:II2-45.
  3. Roy PM, Colombet I, Durieux P, Chatellier G, Sors H, Meyer G. Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. Bmj 2005; 331:259.
  4. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:401S-428S.
  5. Perrier A, Roy PM, Aujesky D, et al. Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med 2004; 116:291-9.
  6. Le Gal G, Righini M, Roy PM, et al. Derivation and validation of a simple standardized clinical score to predict pulmonary embolism in emergency patients: the revised geneva score. Ann Intern Med 2005; In press.

연구 유형

중재적

등록 (예상)

1331

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

      • Argenteuil, 프랑스, 95107
        • H Argenteuil
      • Besançon, 프랑스, 25000
        • UH Besançon
      • Bethune, 프랑스, 62408
        • H Bethune
      • Boulogne Billancourt, 프랑스, 92100
        • UH Ambroise Pare
      • Caen, 프랑스, 14033
        • UH Caen
      • Chalons-en-Champagne, 프랑스, 51005
        • H Chalons en Champagne
      • Chateauroux, 프랑스, 36019
        • H Chateauroux
      • Compiegne, 프랑스, 60200
        • H Compiegne
      • Dijon, 프랑스, 21033
        • UH Dijon
      • Dreux, 프랑스, 28107
        • H Dreux
      • Grenoble, 프랑스, 38043
        • UH Grenoble
      • Langres, 프랑스, 52200
        • H Langres
      • Le Mans, 프랑스, 72037
        • H le Mans
      • Lons le Saunier, 프랑스, 39016
        • H Lons le Saunier
      • Nancy, 프랑스, 54035
        • UH Nancy
      • Paris, 프랑스, 75651
        • UH La Pitie Salpetriere
      • Roanne, 프랑스, 42328
        • H Roanne
      • Saint Nazaire, 프랑스, 44606
        • H Saint Nazaire
      • Thouars, 프랑스, 79100
        • H Thouars
      • Toulouse, 프랑스, 31059
        • Uh Toulouse

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 어린이
  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • patient with suspected pulmonary embolism
  • prescription of a specific paraclinical diagnostic investigation or start of a specific treatment for pulmonary embolism

Exclusion Criteria:

  • confirmation or exclusion of pulmonary embolism before admission in emergency department
  • confirmation of deep venous thrombosis before admission in emergency department
  • suspicion of pulmonary embolism during hospitalization (in-patient)
  • suspicion of pulmonary embolism without investigation realization
  • patient already included in the study
  • patient refusing the utilization of his data for the study

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
rate of agreement between the diagnostic criteria applied in daily practice and those validated in the scientific literature

2차 결과 측정

결과 측정
-(diagnostic intervention) Rate of strategies considered as validated or acceptable according to the opinion of international advisors.
- (diagnostic intervention) Rate of thromboembolic-events during a 3-month follow-up period in patients for whom pulmonary embolism will be ruled out
- (diagnostic intervention) Costs of the diagnostic management
- (therapeutic reminders) Delay between Emergency Department admission and the first dose of antithrombotic treatment in patients with high clinical probability of PE according to the Revised Geneva Score
- (therapeutic reminders)Rate of inappropriate treatment according to international recommendations for patients with confirmed PE.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Pierre-Marie Roy, MD, PhD, UH Angers

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작

2005년 6월 1일

연구 완료 (실제)

2006년 9월 1일

연구 등록 날짜

최초 제출

2005년 9월 12일

QC 기준을 충족하는 최초 제출

2005년 9월 12일

처음 게시됨 (추정)

2005년 9월 16일

연구 기록 업데이트

마지막 업데이트 게시됨 (추정)

2009년 2월 5일

QC 기준을 충족하는 마지막 업데이트 제출

2009년 2월 4일

마지막으로 확인됨

2009년 2월 1일

추가 정보

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

폐 색전증에 대한 임상 시험

Computer-Assisted diagnostic Decision Support에 대한 임상 시험

3
구독하다